|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rabasseda X: A report from the world
conference on lung cancer (September 6–9, 2015-Denver, Colorado,
USA). Drugs Today (Barc). 51:559–567. 2015.PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimasaki S, Shimonaka M, Zhang HP and
Ling N: Identification of five different insulin-like growth factor
binding proteins (IGFBPs) from adult rat serum and molecular
cloning of a novel IGFBP-5 in rat and human. J Biol Chem.
266:10646–10653. 1991.PubMed/NCBI
|
|
5
|
Mohan S, Nakao Y, Honda Y, Landale E,
Leser U, Dony C, Lang K and Baylink DJ: Studies on the mechanisms
by which insulin-like growth factor (IGF) binding protein-4
(IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol
Chem. 270:20424–20431. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mosig RA, Lobl M, Senturk E, Shah H, Cohen
S, Chudin E, Fruscio R, Marchini S, D'Incalci M, Sachidanandam R,
et al: IGFBP-4 is a candidate serum biomarker for detection and
surveillance of early stage epithelial ovarian cancer. Research.
2:13422015. View Article : Google Scholar
|
|
7
|
Mosig RA, Lobl M, Senturk E, Shah H, Cohen
S, Chudin E, Fruscio R, Marchini S, D'Incalci M, Sachidanandam R,
et al: IGFBP-4 tumor and serum levels are increased across all
stages of epithelial ovarian cancer. J Ovarian Res. 5:32012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Drivdahl RH, Sprenger C, Trimm K and
Plymate SR: Inhibition of growth and increased expression of
insulin-like growth factor-binding protein-3 (IGFBP-3) and-6 in
prostate cancer cells stably transfected with antisense IGFBP-4
complementary deoxyribonucleic acid. Endocrinology. 142:1990–1998.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu W and Li Y: Salinomycin suppresses LRP6
expression and inhibits both Wnt/β-catenin and mTORC1 signaling in
breast and prostate cancer cells. J Cell Biochem. 115:1799–1807.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al Dhaheri Y, Attoub S, Arafat K, Abuqamar
S, Eid A, Al Faresi N and Iratni R: Salinomycin induces apoptosis
and senescence in breast cancer: Upregulation of p21,
downregulation of survivin and histone H3 and H4 hyperacetylation.
Biochim Biophys Acta. 1830:3121–3135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fitzgibbons PL, Bradley LA, Fatheree LA,
Alsabeh R, Fulton RS, Goldsmith JD, Haas TS, Karabakhtsian RG,
Loykasek PA, Marolt MJ, et al: Principles of analytic validation of
immunohistochemical assays: Guideline from the College of American
Pathologists Pathology and Laboratory Quality Center. Arch Pathol
Lab Med. 138:1432–1443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mellors RC: The application of labeled
antibody technics in studying cell antigens. Cancer Res.
28:1372–1381. 1968.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Durai R, Davies M, Yang W, Yang SY,
Seifalian A, Goldspink G and Winslet M: Biology of insulin-like
growth factor binding protein-4 and its role in cancer (review).
Int J Oncol. 28:1317–1325. 2006.PubMed/NCBI
|
|
16
|
Diehl D, Lahm H, Wolf E and Bauersachs S:
Transcriptome analysis of a human colorectal cancer cell line shows
molecular targets of insulin-like growth factor-binding protein-4
overexpression. Int J Cancer. 113:588–599. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Resham K, Patel PN, Thummuri D, Guntuku L,
Shah V, Bambal RB and Naidu VG: Preclinical drug metabolism and
pharmacokinetics of salinomycin, a potential candidate for
targeting human cancer stem cells. Chem Biol Interact. 240:146–152.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kopp F, Hermawan A, Oak PS, Herrmann A,
Wagner E and Roidl A: Salinomycin treatment reduces metastatic
tumor burden by hampering cancer cell migration. Mol Cancer.
13:162014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naujokat C and Steinhart R: Salinomycin as
a drug for targeting human cancer stem cells. J Biomed Biotechnol.
2012:9506582012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ,
Zou CY, Xie XB, Zeng YX, Shen JN, Kang T and Wang J: Salinomycin
inhibits osteosarcoma by targeting its tumor stem cells. Cancer
Lett. 311:113–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patel N, Baranwal S and Patel BB: A
strategic approach to identification of selective inhibitors of
cancer stem cells. Methods Mol Biol. 1229:529–541. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Uhlen M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ponten F, Jirström K and Uhlen M: The
human protein Atlas-a tool for pathology. J Pathol. 216:387–393.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Y, Xu H, Huang W, Ding M, Xiao J,
Yang D, Li H, Liu XY and Chu L: Targeting lung cancer stem-like
cells with TRAIL gene armed oncolytic adenovirus. J Cell Mol Med.
19:915–923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen K, Huang YH and Chen JL:
Understanding and targeting cancer stem cells: Therapeutic
implications and challenges. Acta Pharmacol Sin. 34:732–740. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pine SR, Marshall B and Varticovski L:
Lung cancer stem cells. Dis Markers. 24:257–266. 2008. View Article : Google Scholar : PubMed/NCBI
|
